| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 02/26/2003 | CN1399679A Altering gene expression with ssDNA produced in vivo |
| 02/26/2003 | CN1399678A Human Enzymes of metalloprotease family |
| 02/26/2003 | CN1399675A Method of proliferating natural killer cells |
| 02/26/2003 | CN1399645A Human monolonal antibodies to HER2/NEU |
| 02/26/2003 | CN1399644A Novel human G-Protein coupled receptor |
| 02/26/2003 | CN1399643A Primary nucleotide sequence of shrimp white spot bacilliform virus (WSBV), discovery system containing this sequence and detection kit and antiviral targets for detection and controlling shrimp |
| 02/26/2003 | CN1399559A Micro-cluster liquids and methods of making and using them |
| 02/26/2003 | CN1399512A Stress-resistant oversized transgenic plant capable of growing in salinized soil |
| 02/26/2003 | CN1398644A Stem cell regenerating surface cornea and its application in corneal transplantation |
| 02/26/2003 | CN1102174C Ribozyme |
| 02/26/2003 | CA2420656A1 Antisense oligonucleotides against vanilloid receptor 1 |
| 02/25/2003 | US6525243 Unactivated oocytes as cytoplast recipients of quiescent cell nuclei while maintaining correct ploidy |
| 02/25/2003 | US6525242 Preparation of non-human animals having chimeric livers for use of animal models for human liver toxins; immunocompetent animals are rendered tolerant to human hepatocytes by cell or lysate administration during embryonic or neonate stage |
| 02/25/2003 | US6525187 Polynucleotide encoding autoantigens associated with endometriosis |
| 02/25/2003 | US6525180 Antibodies to mammalian T cell surface antigen |
| 02/25/2003 | US6525179 Methods and compositions for impairing multiplication of HIV-1 |
| 02/25/2003 | US6525178 PGC-1, a novel brown fat PPARgamma coactivator |
| 02/25/2003 | US6525030 Gene delivery to periosteal cells by microneedle injection |
| 02/25/2003 | US6524860 Methods for improving sheath fluids and collection systems for sex-specific cytometer sorting of sperm |
| 02/25/2003 | US6524856 Use of consensus sequences for targeted homologous gene isolation and recombination in gene families |
| 02/25/2003 | US6524855 Methods for inducing the differentiation of monocytes into functional dendritic cells |
| 02/25/2003 | US6524852 To eliminate the embryonic capsule, or to increase permeability of the embryonic capsule to enhance subsequent action of cryoprotectants by enzymatic or mechanical means |
| 02/25/2003 | US6524841 Recombinant megalomicin biosynthetic genes and uses thereof |
| 02/25/2003 | US6524837 Hydantoinase variants with improved properties and their use for the production of amino acids |
| 02/25/2003 | US6524834 Protein capable of hydrolyzing organophosphorous acetylcholinesterase inhibitors for use as poison antedote |
| 02/25/2003 | US6524828 Mutant of RNA polymerases with increased stability |
| 02/25/2003 | US6524824 Compositions and methods for non-targeted activation of endogenous genes |
| 02/25/2003 | US6524821 Anti-apoptotic compositions comprising the R1 subunit of herpes simplex virus ribonucleotide reductase or its N-terminal portion; and uses thereof |
| 02/25/2003 | US6524819 And their use in the screening for compounds of use in characterization, diagnosis, and treatment of conditions such as Alzheimer's disease, Down syndrome and other forms of dementia |
| 02/25/2003 | US6524818 Compositions and methods for non-targeted activation of endogenous genes |
| 02/25/2003 | US6524817 DNA encoding a receptor subunit for oncostatin M |
| 02/25/2003 | US6524815 A promoter which is active in the vascular endothelium and to its use for expressing genes of interest in this tissue |
| 02/25/2003 | US6524813 Novel polynucleotides and polypeptides of the spo0J family derived from Staphylococcus |
| 02/25/2003 | US6524806 Methods of screening for ligands of human hemetopoietin receptor HU-B1.219 |
| 02/25/2003 | US6524802 Methods of detecting growth differentiation factor-14 |
| 02/25/2003 | US6524799 DNA encoding sparc-related proteins |
| 02/25/2003 | US6524796 Selecting proteins that binds to said promoter DNA; introducing DNA coding for said proteins into cells carrying a reporter gene; testing for presence of said reporter gene expression product |
| 02/25/2003 | US6524789 Human neuronal nicotinic acetylcholine receptor compositions and methods employing same |
| 02/25/2003 | US6524787 Culturing tumor cells in three dimensional matrices to determine if they form vasculature, thereby determining melanoma has the propensity to become virulent or aggressive if said vasculature forms or not if not |
| 02/25/2003 | US6524583 Inhibit angiogenesis and induce tumor regression, and have improved safety due to their specificity |
| 02/25/2003 | US6524582 Methods and compositions for impairing multiplication of HIV-1 |
| 02/25/2003 | US6524579 Diagnosing, treating or preventing disorders associated with expression of RNABP, cancer, immune disorder, developmental disorders |
| 02/25/2003 | CA2031532C Method for implanting large volumes of cells on polymeric matrices |
| 02/25/2003 | CA1341422C Retinoic acid receptor composition and method |
| 02/24/2003 | WO2002016556A1 Stem cell culture medium and culture method by using the same |
| 02/24/2003 | CA2420416A1 Stem cell culture medium and culture method by using the same |
| 02/21/2003 | WO2002014523A2 Methods for stable transformation of plants |
| 02/21/2003 | CA2399325A1 Carbohydrate-based whole cell cancer vaccines |
| 02/20/2003 | WO2003014703A2 Nucleic acids, polypeptides, single nucleotide polymorphisms and methods of use thereof |
| 02/20/2003 | WO2003014383A2 Phenotypic effects of ubiquinone deficiencies and methods of screening thereof |
| 02/20/2003 | WO2003014381A1 System for detecting protease |
| 02/20/2003 | WO2003014366A2 Rna amplification system using plant components in animal cells |
| 02/20/2003 | WO2003014361A1 Novel recombinant gene expression method by stop codon suppression |
| 02/20/2003 | WO2003014359A2 A fusion protein |
| 02/20/2003 | WO2003014357A1 Wheat plants having increased resistance to imidazolinone herbicides |
| 02/20/2003 | WO2003014356A1 Wheat plants having increased resistance to imidazolinone herbicides |
| 02/20/2003 | WO2003014342A2 Identification of a dna variant associated with adult type hypolactasia |
| 02/20/2003 | WO2003014337A2 Fusion of cells |
| 02/20/2003 | WO2003014336A1 Process for preparing hematopoietic stem cells |
| 02/20/2003 | WO2003014335A1 Process for the maturation of dentritic cells and a vaccine |
| 02/20/2003 | WO2003014334A1 Cell culture method for obtaining prostate-like acini |
| 02/20/2003 | WO2003014333A1 Use of lysyl oxidase inhibitors for cell culture and tissue engineering |
| 02/20/2003 | WO2003014332A1 The application of b-staged divinylsiloxane-bis-benzocyclobutene for the growth and cultivation of biological materials |
| 02/20/2003 | WO2003014331A1 Erythrocytic cells and method for preserving cells |
| 02/20/2003 | WO2003014328A2 Methods and compounds for disruption of cd40r/cd40l signaling in the treatment of alzheimer's disease |
| 02/20/2003 | WO2003014326A2 Isolation and mobilization of stem cells expressing vegfr-1 |
| 02/20/2003 | WO2003014323A2 Human smooth muscle myosin heavy chain |
| 02/20/2003 | WO2003014322A2 Proteins associated with cell growth, differentiation, and death |
| 02/20/2003 | WO2003014320A2 Telomerase immortalized human neutral stem cells and phenotypically-restricted progenitor cells |
| 02/20/2003 | WO2003014318A2 Methods for treating diabetes and other blood sugar disorders |
| 02/20/2003 | WO2003014317A2 Compositions and methods for isolation, propagation, and differentiation of human stem cells and uses thereof |
| 02/20/2003 | WO2003014314A2 13 human secreted proteins |
| 02/20/2003 | WO2003014313A2 Alternative compositions and methods for the culture of stem cells |
| 02/20/2003 | WO2003014310A2 Dna encoding rat bombesin receptor subtype-3 (brs-3) and uses thereof |
| 02/20/2003 | WO2003014305A2 Eukaryotic cells and method for preserving cells |
| 02/20/2003 | WO2003014297A2 Compositions and methods relating to the daptomycin biosynthetic gene cluster |
| 02/20/2003 | WO2003014294A2 Tacis and br3 polypeptides and uses thereof |
| 02/20/2003 | WO2003014149A2 Genetically modified cyclic-nucleotide controlled ion channels and the use thereof |
| 02/20/2003 | WO2003013602A1 Inhibitors of her3 activity |
| 02/20/2003 | WO2003013595A1 Compounds and methods for the modulation of immune responses |
| 02/20/2003 | WO2003013588A1 Kidney regeneration material comprising cells and cell growth factor |
| 02/20/2003 | WO2003013570A1 Platelet-derived growth factor protection of cardiac myocardium |
| 02/20/2003 | WO2003013431A2 Compositions and methods for the therapy and diagnosis of breast cancer |
| 02/20/2003 | WO2003013422A2 Methods for the treatment and prognosis of leukemia and other cancer types |
| 02/20/2003 | WO2003000851A3 Method for rapid screening of bacterial transformants and novel simian adenovirus proteins |
| 02/20/2003 | WO2002099138A3 HS2STs AS MODIFIERS OF THE P53 PATHWAY AND METHODS OF USE |
| 02/20/2003 | WO2002098369A3 Mutant forms of cholera holotoxin as an adjuvant |
| 02/20/2003 | WO2002098360A3 Stress protein compositions and methods for prevention and treatment of cancer and infectious disease |
| 02/20/2003 | WO2002094987A3 In vitro production of haploid germ cells |
| 02/20/2003 | WO2002094874A3 Internalisation of virus into cells |
| 02/20/2003 | WO2002094862A3 Hypoxia inducible factors and uses thereof for inducing angiogenesis and improving muscular functions |
| 02/20/2003 | WO2002092758A8 Gastrokines and derived peptides including inhibitors |
| 02/20/2003 | WO2002086085A3 Human timp-1 antibodies |
| 02/20/2003 | WO2002083849A3 Vascular endothelial growth factor 2 |
| 02/20/2003 | WO2002081628A3 Modulation of gene expression associated with inflammation proliferation and neurite outgrowth, using nucleic acid based technologies |
| 02/20/2003 | WO2002077264A3 Arrayed transfection method and uses related thereto |
| 02/20/2003 | WO2002072762A3 Use of rna interference for the creation of lineage specific es and other undifferentiated cells and production of differentiated cells in vitro by co-culture |
| 02/20/2003 | WO2002068605A3 Non-oligomerizing tandem fluorescent proteins |
| 02/20/2003 | WO2002066505A3 Gmg-3, gmg-4, and gmg-6 polynucleotides and polypeptides and uses thereof |
| 02/20/2003 | WO2002064666A3 Substrates containing polyphosphazene as matrixs and with a microstructured surface |